Announcements Trials

Browse Landscape

Phase

Status

Recruiting 3 Completed 3 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lymphangioleiomyomatosis 1

Interventions

Cisplatin 509 Cyclophosphamide 360 Carboplatin 352 Radiotherapy 350 Capecitabine 329 Paclitaxel 325 Oxaliplatin 324 Gemcitabine 319 Docetaxel 311 Fluorouracil 284 Drug Therapy 244 apatinib 242 Bevacizumab 230 camrelizumab 214 Etoposide 200 Irinotecan 177 Doxorubicin 175 Leucovorin 162 Dexamethasone 160 sintilimab 142 pembrolizumab 140 anlotinib 136 Pemetrexed 136 Cytarabine 136 toripalimab 129 Neoadjuvant Therapy 122 S 1 (combination) 120 Vincristine 119 Rituximab 117 Radiosurgery 117

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Interventional × Loratadine × Clear all

NCT05190627 2022-01-27

LORALAM

Institut d'Investigació Biomèdica de Bellvitge

Phase 2 Unknown

Lymphangioleiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡